Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2009. Start Trial.
Date Value
June 30, 2026 0.066M
March 31, 2026 -0.014M
December 31, 2025 0.18M
September 30, 2025 -0.111M
June 30, 2025 26.77M
March 31, 2025 1.085M
December 31, 2024 1.132M
September 30, 2024 30.31M
June 30, 2024 -0.197M
March 31, 2024 29.28M
December 31, 2023 0.00
September 30, 2023 -0.108M
June 30, 2023 6.923M
March 31, 2023 1.352M
December 31, 2022 0.339M
September 30, 2022 0.133M
June 30, 2022 0.233M
March 31, 2022 -1.28M
December 31, 2021 2.426M
September 30, 2021 0.868M
June 30, 2021 0.456M
March 31, 2021 0.017M
December 31, 2020 81.59M
September 30, 2020 0.125M
June 30, 2020 0.116M
Date Value
March 31, 2020 -1.019M
December 31, 2019 2.422M
September 30, 2019 1.688M
June 30, 2019 51.93M
March 31, 2019 -2.082M
December 31, 2018 0.251M
September 30, 2018 2.40M
June 30, 2018 38.68M
March 31, 2018 -2.764M
December 31, 2017 0.033M
September 30, 2017 -0.12M
June 30, 2017 23.28M
March 31, 2017 -1.547M
December 31, 2016 0.094M
September 30, 2016 0.077M
June 30, 2016 0.43M
March 31, 2016 -1.091M
December 31, 2015 1.866M
September 30, 2015 0.039M
June 30, 2015 -1.183M
March 31, 2015 -0.433M
December 31, 2014 0.024M
September 30, 2014 0.118M
June 30, 2014 0.23M
March 31, 2014 -0.168M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Lifecore Biomedical, Inc. -0.852M
Quanterix Corp. -0.527M
Frontage Holdings Corp. --
Repligen Corp. -6.20M
Bio-Techne Corp. -33.21M